The ERA Registry Annual Report 2020: a summary

被引：40

作者：

Astley, Megan E. ^{[1
,2
]}

Boenink, Rianne ^{[1
,3
]}

Abd ElHafeez, Samar ^{[1
,4
]}

Trujillo-Aleman, Sara ^{[5
]}

Arribas, Federico ^{[6
]}

Asberg, Anders ^{[7
]}

Beckerman, Pazit ^{[8
,9
]}

Bell, Samira ^{[10
,11
]}

Bouzas-Caamano, Maria Encarnacion ^{[12
]}

Farnes, Jordi Comas ^{[13
]}

Galvao, Ana Amelia ^{[14
]}

Gjorgjievski, Nikola ^{[15
,16
]}

Kelmendi, Vjollca Godanci ^{[17
]}

Guidotti, Rebecca ^{[18
]}

Helve, Jaakko ^{[19
,20
,21
]}

Idrizi, Alma ^{[22
]}

Indridason, Olafur S. ^{[23
]}

Ioannou, Kyriakos ^{[24
]}

Kerschbaum, Julia ^{[25
]}

Komissarov, Kirill ^{[26
]}

de la Nuez, Pablo Castro ^{[27
]}

Lassalle, Mathilde ^{[28
]}

Nordio, Maurizio ^{[29
]}

Arevalo, Olga Lucia Rodriguez ^{[30
,31
]}

Santiuste, Carmen ^{[32
,33
]}

Seyahi, Nurhan ^{[34
]}

Roblero, Maria Fernanda Slon ^{[35
]}

Steenkamp, Retha ^{[36
]}

ten Dam, Marc A. G. J. ^{[37
]}

Zakharova, Elena, V ^{[38
,39
]}

Ziginskiene, Edita ^{[40
,41
]}

Bonthuis, Marjolein ^{[1
,42
,43
]}

Stel, Vianda S. ^{[1
,3
]}

Ortiz, Alberto ^{[44
,45
]}

Jager, Kitty J. ^{[1
,3
]}

Kramer, Anneke ^{[1
]}

机构：

[1] Amsterdam UMC Locat Univ Amsterdam, ERA Registry, Dept Med Informat, Amsterdam, Netherlands

[2] Amsterdam Publ Hlth, Hlth Behav & Chron Dis & Methodol, Amsterdam, Netherlands

[3] Amsterdam Publ Hlth, Qual Care & Ageing & Later Life, Amsterdam, Netherlands

[4] Alexandria Univ, High Inst Publ Hlth, Epidemiol Dept, Alexandria, Egypt

[5] Serv Canario Salud, Hlth Qual Assessment & Informat Syst Serv, Direcc Gen Programas Asistenciales, Las Palmas Gran Canaria, Canary Islands, Spain

[6] Gen Direct Hlth Care, Dept Aragon Hlth, Zaragoza, Spain

[7] Natl Hosp Norway, Oslo Univ Hosp, Norwegian Renal Registry, Dept Transplantat Med, Oslo, Norway

[8] Sheba Med Ctr, Ramat Gan, Israel

[9] Tel Aviv Univ, Sch Med, Tel Aviv, Israel

[10] Publ Hlth Scotland, Scottish Renal Registry, Glasgow, Lanark, Scotland

[11] Univ Dundee, Ninewells Hosp, Div Populat Hlth & Genom, Dundee, Scotland

[12] Galician Hlth Serv, Reg Transplant Coordinat Galicia, Santiago De Compostela, Spain

[13] Generalitat Catalonia, Catalan Transplant Org, Catalan Renal Registry, Hlth Dept, Barcelona, Spain

[14] Portuguese Soc Nephrol, Coimbra, Portugal

[15] Hosp Nephrol, Skopje, North Macedonia

[16] Univ SS Cyril & Methodius Skopje, Fac Med, Skopje, North Macedonia

[17] Univ Clin Ctr Kosova, Nephrol Clin, Prishtina, Kosovo

[18] City Hosp Zurich, Inst Nephrol, Zurich, Switzerland

[19] Univ Helsinki, Finnish Registry Kidney Dis, Helsinki, Finland

[20] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland

[21] Helsinki Univ Cent Hosp, Helsinki, Finland

[22] UHC Mother Teresa, Serv Nephrol, Tirana, Albania

[23] Landspitali Natl Univ Hosp Iceland, Div Nephrol, Reykjavik, Iceland

[24] Cyprus Renal Registry, Nicosia, Cyprus

[25] Med Univ Innsbruck, Dept Internal Med Nephrol & Hypertens 4, Austrian Dialysis & Transplant Registry, Innsbruck, Austria

[26] Minsk Sci & Pract Ctr Surg Transplantat & Hematol, Minsk, BELARUS

[27] SICATA Informat Syst Autonomous Coordinat Transpl, Seville, Andalucia, Spain

[28] Agence Biomed, REIN Registry, La Plaine St Denis, France

[29] Treviso Gen Hosp, AULSS 2, Div Nephrol, Treviso, Italy

[30] Minist Universal Hlth & Publ Hlth, Registry Renal Patients Valencian Community, Gen Directorate Publ Hlth & Addict, Valencia, Spain

[31] Univ Politecn Valencia, Hlth & Well Being Technol Program, Valencia, Spain

[32] IMIB Arrixaca, Murcia Reg Hlth Council, Murcia Renal Registry, Dept Epidemiol, Murcia, Spain

[33] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

[34] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Nephrol, Istanbul, Turkiye

[35] Hosp Univ Navarra, Navarra, Spain

[36] UK Renal Registry, Bristol, Avon, England

[37] Nefrovisie, Dutch Registry RENINE, Utrecht, Netherlands

[38] Botkin Hosp, Nephrol, Moscow, Russia

[39] Russian Med Acad Continuing Profess Educ, Nephrol & Hemodialysis, Moscow, Russia

[40] Lithuanian Nephrol Dialysis & Transplantat Assoc, Kaunas, Lithuania

[41] Lithuanian Univ Hlth Sci, Med Acad, Nephrol Dept, Kaunas, Lithuania

[42] Amsterdam Publ Hlth, Qual Care, Amsterdam, Netherlands

[43] Amsterdam UMC Locat Univ Amsterdam, Dept Med Informat, ESPN ERA Registry, Amsterdam, Netherlands

[44] IIS Fdn Jimenez Diaz UAM, Dept Nephrol & Hypertens, Madrid, Spain

[45] Univ Autonoma Madrid, Dept Med, Madrid, Spain

来源：

CLINICAL KIDNEY JOURNAL | 2023年 / 16卷 / 08期

关键词：

dialysis; epidemiology; ESKD; kidney transplantation; patient survival;

D O I：

10.1093/ckj/sfad087

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Background The European Renal Association (ERA) Registry collects data on kidney replacement therapy (KRT) in patients with ESKD. This paper is a summary of the ERA Registry Annual Report 2020, also including comparisons among primary renal disease (PRD) groups. Methods Data were collected from 52 national and regional registries from 34 European countries and countries bordering the Mediterranean Sea: 35 registries from 18 countries providing individual level data and 17 registries from 17 countries providing aggregated data. Using this data, KRT incidence and prevalence, kidney transplantation rates, expected remaining lifetimes and survival probabilities were calculated. Results A general population of 654.9 million people was covered by the ERA Registry in 2020. The overall incidence of KRT was 128 per million population (p.m.p.). In incident KRT patients, 54% were older than 65 years, 63% were men and the most common PRD was diabetes mellitus (21%). Regarding initial treatment modality in incident patients, 85% received haemodialysis (HD), 11% received peritoneal dialysis (PD) and 4% received a pre-emptive kidney transplant. On 31 December 2020, the prevalence of KRT was 931 p.m.p. In prevalent patients, 45% were older than 65 years, 60% were men and glomerulonephritis was the most common PRD (18%). Of these patients, 58% were on HD, 5% on PD and 37% were living with a kidney transplant. The overall kidney transplantation rate in 2020 was 28 p.m.p., with a majority of kidney grafts from deceased donors (71%). The unadjusted 5-year survival, based on incident dialysis patient from 2011-15, was 41.8%. For patients having received a deceased donor transplant, the unadjusted 5-year survival probability was 86.2% and for patients having received a living donor transplant it was 94.4%. When comparing data by PRD group, differences were found regarding the distribution of age groups, sex and treatment modality received.

引用

页码：1330 / 1354

页数：25